C. Mark Mckenna
Affiliations
- Director at Apogee Therapeutics Inc. (APGE), 2024-12-16
- at Newamsterdam Pharma Co N.v. (NAMS), 2024-07-19
- at Perceptive Capital Solutions Corp (PCSC), 2024-06-11
- Director at Helix Acquisition Corp. Ii (HLXB), 2024-02-09
- at Spyre Therapeutics Inc. (SYRE), 2024-02-05
- Chairman, President And Ceo at Prometheus Biosciences Inc. (RXDX), 2023-06-16
- President, Salix at Bausch Health Companies Inc. (BHC), 2019-08-21
Insider Trading: Purchases See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| APGE | $49.85 | 12,500 | Director | 20,000 | 2024-12-12 | Filing | |
| APGE | $49.02 | 7,500 | Director | 7,500 | 2024-12-12 | Filing |
Insider Trading: Sales See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| RXDX | $116.14 | 25,000 | Officer, Director | 55,144 | 2023-03-15 | Filing | |
| RXDX | $125.13 | 10,620 | Officer, Director | 55,144 | 2023-03-03 | Filing | |
| RXDX | $125.26 | 700 | Officer, Director | 55,144 | 2023-03-01 | Filing | |
| RXDX | $125.10 | 13,680 | Officer, Director | 55,144 | 2023-02-17 | Filing | |
| RXDX | $119.87 | 25,000 | Officer, Director | 55,144 | 2023-02-16 | Filing |